China News Network on March 3 Question: Reward 25 million yuan! Who is TA? How to "take orders"?
Zhongxin financial reporter Zuo Yukun
Execution target:
The subject matter of the case was $1,112,311,877.27 and interest on the debt during the period of delay.
Bounty conditions:
Where the whistleblower provides clues about assets that can be enforced and verified to be true (excluding clues already in the possession of the court), a reward of 10% of the amount of execution in place will be given.
On March 3, the WeChat public account of "Beijing Second Intermediate Court Golden Balance" issued a reward announcement, because whistleblowers can get a high reward of up to 23 million yuan, and many netizens commented that "the opportunity to make a fortune has arrived".
How can I get a rare sky-high bounty? What is the origin of Zhu Jiman and Bai Lihui, who were publicly rewarded?
Screenshot of part of the bounty announcement.
100 million yuan bounty, can you really get it?
The maximum bounty of 1 million yuan is undoubtedly the biggest highlight of this announcement. Where does this money come from? First of all, it is important to clarify the definition of a reward in the law.
An Xiang, director of Beijing Dexiang Law Firm, told Zhongxin Financial Reporter that according to the Provisions of the Supreme People's Court on Several Issues Concerning Property Investigation in Civil Enforcement (2020 Revision), during the enforcement procedure, the applicant for enforcement voluntarily submits an application to the court, that is, submits an application to the court. The content of the application is: If any person provides enforceable property clues that are not yet available to the court, and the applicant voluntarily pays part of the amount to reward the person who provided the information, this is an enforcement reward.
"If the court approves the application, it will issue such a reward announcement, in which the conditions, content, amount, method, etc. of the reward will be clearly defined." An Xiang said that the bounty bonus is calculated according to 10% in this announcement, that is, if someone provides a clue, the final effect of execution will be rewarded.
However, it is not as long as you provide clues to get 100 million yuan, and the amount of the bounty depends on how much execution is finally achieved in the clues provided.
"For example, if someone provides clues about the property of the person subject to enforcement of 100 million yuan, and then the court investigates the successful execution based on the clues, then the applicant will take 100% of the 10 million yuan, that is, 10,<> yuan to reward the person who provided the clue." An Xiang said.
From ophthalmologist to "the richest man in Heilongjiang"
According to public information, one of the executors in the announcement, Zhu Jiman, is a native of Xi'an, Shaanxi Province, born in 1964. After graduating from medical university, he entered a hospital in Xi'an as an ophthalmologist, and during this work experience, he also met his wife Bai Lihui, another executor in the announcement.
But Zhu Jiman is not satisfied with the steady work of the hospital. In 1992, Zhu Jiman lost his "iron rice bowl" and went to the sea to do business, engaged in drug agency sales work that was quite related to his old bank. From the bottom sales to the senior manager, Zhu Jiman also came to the northeast from the northwest, gradually found out the situation of the northeast pharmaceutical enterprises, and was determined to set up his own portal.
In 2000, Zhu Jiman bought the bankrupt Heilongjiang Rehabilitation Research Institute affiliated pharmaceutical factory for 168.2010 million yuan and transformed it into Yuheng Pharmaceutical. With sharp commercial methods, this small pharmaceutical company that has been losing money for many years has regained new opportunities in the hands of Zhu Jiman and was successfully listed on the Shenzhen Stock Exchange in 320, with a market value of more than <> billion yuan at its peak.
Zhu Jiman. The screenshot is from the official website of Heng Pharmaceutical.
After the listing, Yuheng Pharmaceutical was even more unwilling to just silently "pharmaceutical". Zhu Jiman, who came from a sales background, embarked on the road of emphasizing marketing and light R&D, and began frequent mergers and acquisitions and continuous sniping at the control of listed companies.
According to media statistics, Yuheng Pharmaceutical has successively acquired more than 40 pharmaceutical companies such as Harbin Dandelion Pharmaceutical, Aonuo Pharmaceutical, and Shanghai Huatuo, and the radical "Northeast Medicine King" has also been labeled as a "barbarian" in the pharmaceutical industry.
"Once a suitable variety is found, it will be collected by direct purchase, cooperative research and development, mergers and acquisitions, etc. In the next three years, we will have 3 new first-class drugs on the market. Now Yuheng Pharmaceutical is a drug integrator, and the new drug resources will only become less and less. Zhu Jiman said this in an interview with the media before.
This undoubtedly brought great wealth to Zhu Jiman. In 2010, Zhu Jiman and Bai Lihui debuted on the Hurun Report with a net worth of 50 billion yuan, and reached the peak of personal wealth of 2015 billion yuan in 130. In 2017, the couple last ranked 105th on the 2017 list with a wealth of 349.<> billion yuan, and they were still the "richest man in Heilongjiang" that year.
But in 2018, Zhu Jiman and Bai Lihui disappeared from the Hurun Report.
"Northeast Medicine King"'s "chicken feathers"
The hidden thunder of disorderly expansion has long been laid. In the capital market, crazy "buying, buying, buying" is often accompanied by a large amount of debt, which eventually becomes the mountain that crushes Zhu Jiman.
Taking SINBON Pharmaceutical, which entered SINBON Pharmaceutical in 2017, as an example, Yuheng Group acquired SINBON Pharmaceutical for 30 billion yuan through high pledge of equity and loans, and experienced a blow-up in the stock price plunge a year later. The acquisition, known as the snake elephant, became the largest acquisition in the company's history and eventually led to the group's debt crisis.
After the disclosure of the 2019 annual report, the crisis of Yuheng Pharmaceutical was made public: the net profit attributable to the parent that year was -26.62 billion yuan, almost losing all the profits since its listing in 2010, and the performance has continued to be sluggish since then. In July 2020, SINBON Pharmaceutical and Yuheng Pharmaceutical successively announced that their joint controlling shareholder, Yuheng Group, faced bankruptcy reorganization.
In September 2022, Zhu Jiman and Bai Lihui both resigned as directors of Yuheng Pharmaceutical. Finally, in November 9, the Harbin Intermediate Court terminated the reorganization procedure of Yuheng Group and declared Yuheng Group bankrupt. In February this year, the latest announcement of Yuheng Pharmaceutical showed that the shares held by Yuheng Group have been auctioned and sold, and its company will be in a state of no controlling shareholder and no actual controller.
According to the China Enforcement Information Open Network, Zhu Jiman has as many as 40 pieces of enforcement information under his name, ranging from millions of yuan to more than one billion. Many courts have issued "restraining orders" to Zhu Jiman, and Zhu Jiman has also repeatedly become a dishonest defendant, that is, "Lao Lai".
"In March 2000, the first spring of the new century, on the banks of the Songhua River, when my partners and I shoveled the first shovel of soil to lay the foundation stone for Yuheng Pharmaceutical, as the soil fell, we realized that we had made an irrevocable commitment to the public, that is, to abide by the belief of responsibility and honor, to serve the health of the public, and to move forward without fear of hardship."
The founder's speech page of Yuheng Pharmaceutical's official website still retains Zhu Jiman's photos and what he said. But in the list of speeches and management teams, his name is no longer available. (End)